Cargando…
Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance
Chimeric antigen receptor (CAR) T-cell therapy, belonging to adoptive immune cells therapy, utilizes engineered immunoreceptors to enhance tumor-specific killing. By now new generations of CAR T-cell therapies dramatically promote the effectiveness and robustness in leukemia cases. However, only a f...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773088/ https://www.ncbi.nlm.nih.gov/pubmed/36569859 http://dx.doi.org/10.3389/fimmu.2022.1053120 |